Sri Sai Subramanyam Challa. “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”. Journal of Population Therapeutics and Clinical Pharmacology 28, no. 2 (August 25, 2021): 436–448. Accessed November 18, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/7421.